Equities

hVIVO PLC

HVO:LSE

hVIVO PLC

Health CareHealth Care Providers
  • Price (GBX)22.00
  • Today's Change-0.90 / -3.93%
  • Shares traded1.26m
  • 1 Year change21.38%
  • Beta1.1116
Data delayed at least 20 minutes, as of Nov 22 2024 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year hVIVO PLC grew revenues 15.61% from 48.48m to 56.04m while net income improved from a loss of 776.00k to a gain of 16.12m.
Gross margin--
Net profit margin27.10%
Operating margin20.72%
Return on assets25.04%
Return on equity58.04%
Return on investment46.68%
More ▼

Cash flow in GBPView more

In 2023, hVIVO PLC increased its cash reserves by 29.99%, or 8.53m. The company earned 17.24m from its operations for a Cash Flow Margin of 30.76%. In addition the company used 5.18m on investing activities and also paid 3.52m in financing cash flows.
Cash flow per share0.0299
Price/Cash flow per share7.54
Book value per share0.0565
Tangible book value per share0.0482
More ▼

Balance sheet in GBPView more

hVIVO PLC has a Debt to Total Capital ratio of 25.30%, a higher figure than the previous year's 3.23%.
Current ratio1.61
Quick ratio1.60
Total debt/total equity0.3386
Total debt/total capital0.253
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.